Blue Capital Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Blue Capital Inc's BMY Position: Q2 2026 in Review
Blue Capital Inc increased its Bristol-Myers Squibb (BMY) stake by 25% in Q2 2026, buying an estimated $208K and bringing the position to 18,381 shares worth $1.06M. The position accounts for 0.67% of the portfolio, ranked #45.
Blue Capital Inc first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Blue Capital Inc held 18,381 shares of Bristol-Myers Squibb worth $1.06M as of Q2 2026.
- Blue Capital Inc bought 3,627 Bristol-Myers Squibb shares in Q2 2026, an estimated $208K.
- Bristol-Myers Squibb made up 0.67% of Blue Capital Inc's portfolio in Q2 2026, its #45 holding.
- Blue Capital Inc first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Blue Capital Inc's 13F filing for Q2 2026, filed 11 Aug 2026.